The Value of Cerebrospinal Fluid Testing in Guiding Treatment for CNS Cancers | Dr. Daniel Chan

When cancer spreads to the brain, can cerebrospinal fluid (CSF) testing provide answers that blood testing may not?

Dr. Daniel Chan, Medical Oncologist, discusses the growing role of cerebrospinal fluid (CSF) testing in guiding treatment decisions for patients with brain metastases and leptomeningeal disease.

Drawing on a real patient case and the latest NCCN Guidelines, he explains how CSF testing can help identify actionable genetic changes when blood testing or tissue biopsy may not be feasible.